| Literature DB >> 32809973 |
Izuru Mizoguchi1, Mio Ohashi1, Hideaki Hasegawa1, Yukino Chiba1, Naoko Orii1, Shinya Inoue1, Chiaki Kawana1, Mingli Xu1, Katsuko Sudo2, Koji Fujita3, Masahiko Kuroda3, Shin-Ichi Hashimoto4, Kouji Matsushima5, Takayuki Yoshimoto1.
Abstract
Epstein-Barr virus-induced gene 3 (EBI3) is a subunit common to IL-27, IL-35, and IL-39. Here, we explore an intracellular role of EBI3 that is independent of its function in cytokines. EBI3-deficient naive CD4+ T cells had reduced IFN-γ production and failed to induce T cell-dependent colitis in mice. Similarly reduced IFN-γ production was observed in vitro in EBI3-deficient CD4+ T cells differentiated under pathogenic Th17 polarizing conditions with IL-23. This is because the induction of expression of one of the IL-23 receptor (IL-23R) subunits, IL-23Rα, but not another IL-23R subunit, IL-12Rβ1, was selectively decreased at the protein level, but not the mRNA level. EBI3 augmented IL-23Rα expression via binding to the chaperone molecule calnexin and to IL-23Rα in a peptide-dependent manner, but not a glycan-dependent manner. Indeed, EBI3 failed to augment IL-23Rα expression in the absence of endogenous calnexin. Moreover, EBI3 poorly augmented the expression of G149R, an IL-23Rα variant that protects against the development of human colitis, because binding of EBI3 to the variant was reduced. Taken together with the result that EBI3 expression is inducible in T cells, the present results suggest that EBI3 plays a critical role in augmenting IL-23Rα protein expression via calnexin under inflammatory conditions.Entities:
Keywords: Chaperones; Cytokines; Immunology; Inflammation
Year: 2020 PMID: 32809973 PMCID: PMC7598073 DOI: 10.1172/JCI122732
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808